Compare LENZ & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | INTT |
|---|---|---|
| Founded | 2019 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 139.2M |
| IPO Year | 2021 | 1997 |
| Metric | LENZ | INTT |
|---|---|---|
| Price | $4.13 | $11.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $44.00 | $13.50 |
| AVG Volume (30 Days) | ★ 638.5K | 96.3K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $19,088,000.00 | ★ $66,801,000.00 |
| Revenue This Year | $50.42 | $15.82 |
| Revenue Next Year | $197.16 | $9.10 |
| P/E Ratio | ★ N/A | $183.17 |
| Revenue Growth | N/A | ★ 66.06 |
| 52 Week Low | $4.00 | $7.07 |
| 52 Week High | $50.19 | $20.00 |
| Indicator | LENZ | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 32.97 | 45.18 |
| Support Level | N/A | $11.17 |
| Resistance Level | $6.11 | $11.83 |
| Average True Range (ATR) | 0.29 | 0.47 |
| MACD | -0.10 | 0.11 |
| Stochastic Oscillator | 3.54 | 58.82 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.